Missed a GLP-1 Dose? Wegovy and Zepbound Restart Rules

The short answer: identify the medicine first

A missed injection is a scheduling problem until it becomes a treatment interruption. The useful first question is not whether you have ruined your progress. It is which medicine you take, when you actually last took it, and how many consecutive doses you missed. There is no single rule covering every product called a GLP-1.

The table below covers U.S. branded products. A vial labeled compounded semaglutide or tirzepatide needs instructions from its dispensing pharmacist and prescriber. Do not borrow a branded pen's directions for a different concentration, and do not double a dose to compensate for a missed week. Keep the box or a photograph of the prescription label beside you when asking for advice.

Count from the last dose, not the reminder

The calendar notification may say Thursday even if you took last week's injection on Saturday. Write down the actual administration date and time before applying a missed-dose rule. That distinction matters most when trying to return to your old day after a late injection.

For tirzepatide, MedlinePlus repeats the four-day catch-up window and the instruction not to inject two doses within three days of one another¹. If you are unsure whether a dose went in, describe what happened to the pharmacist instead of treating it as definitely missed. A malfunctioning device, leaking injection and forgotten injection are three different conversations.

For Wegovy, the label distinguishes more than 48 hours from less than 48 hours before the next scheduled injection. At exactly the boundary, or if the date is uncertain, ask the pharmacist to work through the timing with you. The aim is a clear answer written for your calendar, not a hurried estimate while holding a pen.

Two missed Wegovy weeks change the conversation

The June 2026 Wegovy prescribing information says to reinitiate escalation at a lower dosage after two or more consecutive missed injections, to reduce gastrointestinal adverse reactions². That is stronger wording than the manufacturer's consumer FAQ, which still offers taking the next scheduled dose or calling about restarting³. Follow the current prescription plan and have the prescriber resolve that discrepancy; this page does not select a restart strength.

An insurance delay can therefore create two tasks: obtaining medicine and obtaining the right instructions to use it again. Tell the clinician the length of the gap when requesting the refill. A renewal at the old strength is not, by itself, an individualized assessment of restart tolerance.

Ask for the restart dose, the date to take it, the dates of any planned increases, and what symptoms should prompt a call. A portal message that simply says “resume” leaves too much room for interpretation when a medication comes in several strengths.

Zepbound's missed-dose rule is not a long-gap protocol

Lilly's prescribing information provides a rule for a missed dose, but does not supply a universal dose-by-dose restart schedule after several missed weeks⁴. That missing schedule is a reason to ask the prescriber, not permission to invent one from social media. The clinician can consider the interruption, previous tolerance, other medicines and why treatment stopped. A pause around surgery or colonoscopy also needs a coordinated plan for resuming treatment.

Lilly's clinician guidance reports gastrointestinal reactions among participants in the SURMOUNT trials, including some severe reactions⁵. Those were observed clinical experiences, not a prediction that every restart will cause sickness. They explain why “I tolerated that strength before” is useful information for the clinician rather than a complete restart decision.

If vomiting or another adverse effect caused the pause, lead with that information. Do not frame the appointment only as a request to get back to the old dose faster. If you stopped because you became pregnant or a clinician suspected a serious adverse reaction, seek clinical instructions before restarting at any strength.

A daily pill needs its own routine

Wegovy tablets are a daily formulation with their own administration instructions. A missed tablet is skipped; the label does not direct taking two the next day². Keep daily-pill questions separate from weekly-injection rules even though both products contain semaglutide.

A practical reminder should identify the product and formulation, not just say “GLP-1.” That helps a partner supporting your medication routine avoid assuming all boxes in the refrigerator or cabinet work the same way. If your clinician switches the formulation, remove the old reminder and write down the new prescription instructions together.

For a longer pill interruption, ask whether a new titration plan is needed. The fact that a single missed tablet has a simple rule does not answer every question about restarting after a prolonged break.

Make the refill delay visible early

If a shipment is late or the pharmacy cannot fill the next box, send the prescriber the last injection date, current strength, number of doses left and expected delivery date. Ask what to do if the gap reaches a second missed week. Save the response where you keep the dose log.

For mothers managing childcare and work, the most useful plan is one that survives a busy evening. One reminder, one written dose log and one named clinical contact are easier to use than several conflicting screenshots. A household calendar can show the medication appointment without displaying your diagnosis or weight.

You do not owe an apology for forgetting or being unable to obtain a prescription. You do need a plan that is specific enough to act on. Before taking the next dose after a gap, be able to answer: which product, which strength, which day, and whose instructions. If one answer is missing, the pharmacy or prescriber is the next step.